Rocket Pharmaceuticals (RCKT) Misses Q1 EPS by 2c

Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q1 EPS of ($0.42), $0.02 worse than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.

You May Also Be Interested In

• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• XP Inc eyes US banking license as next business step
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance